Trial intelligence / Profile preview

Nortriptyline for nocturnal enuresis in children with ADHD

IRCT201111043930N16Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of nortriptyline in nocturnal enuresis (NE) and attention deficit hyperactivity disorder (ADHD), sponsored by Shiraz University of Medical Sciences. Started Sep 2011; status: completed.

02

Drugs

nortriptyline
03

Conditions

nocturnal enuresis (NE)attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on IRCT201111043930N16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201111043930N16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call